Sansonno D, Cornacchiulo V, Racanelli V, Dammacco F
Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Italy.
Cancer. 1997 Jul 1;80(1):22-33.
The overwhelming evidence that chronic infection with the hepatitis C virus (HCV) is an important cause of hepatocellular carcinoma (HCC) is based on epidemiologic, case-control, and cohort studies as well as laboratory investigations. To address better the pathogenesis of HCV infection at the single-cell level, the authors developed a specific reproducible method for the simultaneous detection of HCV specific sequences and antigens in liver tissue, using a combination of nonradioactive in situ hybridization and immunohistochemistry.
After immunohistochemical staining of the liver sections for E2/NS-1, C22-3, C33c, C100-3, and NS-5 antigens with immunogold-silver technique, in situ hybridization was performed on the same sections using digoxigenin-labeled HCV 5' NonCoding specific probes. The hybridization signal was detected by an antidigoxigenin, Fab fragment-alkaline phosphatase conjugate. This simultaneous detection permitted the subcellular localization of HCV RNA and antigens with excellent preservation of tissue morphology and absence of background staining. In addition, the types and percentages of cells harboring HCV in tissue could be determined.
The in situ detection of HCV showed positive signals in both cancerous and noncancerous areas of liver tissue in six of six HCV-infected patients with HCC and in none of four controls, including three HCV negative HCC patients and one patient with epithelioid hemangioendothelioma. Two classes of infected cells were distinguished throughout the liver: (1) cells containing large amounts of negative-stranded HCV RNA, which were probably undergoing active viral replication; and (2) cells displaying positive-stranded HCV RNA only, with unpredictable levels of viral replication. Both types expressed core, envelope, and NS-3, -4, and -5 proteins. HCV RNA and antigens were exclusively cytoplasmic. Detection of viral proteins was highly predictive of the presence of large amounts of HCV RNA in the same cell. Fewer HCV positive cells were consistently demonstrated in the cancerous area.
These findings support the contention that HCV infects hepatocytes and replicates in them, even after their malignant transformation.
丙型肝炎病毒(HCV)慢性感染是肝细胞癌(HCC)的重要病因,这一压倒性证据基于流行病学、病例对照和队列研究以及实验室调查。为了在单细胞水平更好地研究HCV感染的发病机制,作者开发了一种特异性可重复的方法,通过结合非放射性原位杂交和免疫组化来同时检测肝组织中的HCV特异性序列和抗原。
采用免疫金银技术对肝切片进行E2/NS-1、C22-3、C33c、C100-3和NS-5抗原的免疫组化染色后,使用地高辛标记的HCV 5'非编码特异性探针在同一切片上进行原位杂交。杂交信号通过抗地高辛Fab片段碱性磷酸酶偶联物进行检测。这种同时检测能够实现HCV RNA和抗原的亚细胞定位,组织形态保存良好且无背景染色。此外,还可以确定组织中携带HCV的细胞类型和百分比。
在6例HCV感染的HCC患者的肝组织癌区和非癌区均检测到HCV原位阳性信号,而4例对照中均未检测到,包括3例HCV阴性的HCC患者和1例上皮样血管内皮瘤患者。在整个肝脏中可区分出两类感染细胞:(1)含有大量负链HCV RNA的细胞,可能正在进行活跃的病毒复制;(2)仅显示正链HCV RNA的细胞,病毒复制水平不可预测。两种类型的细胞均表达核心、包膜以及NS-3、-4和-5蛋白。HCV RNA和抗原仅存在于细胞质中。病毒蛋白的检测高度预示同一细胞中存在大量HCV RNA。癌区始终显示较少的HCV阳性细胞。
这些发现支持了HCV即使在肝细胞发生恶性转化后仍能感染并在其中复制的观点。